| 2:30 pm - 4:00 pm |
Oral sessions I, II and III* |
| 2:30 pm - 4:00 pm |
Oral Session I - Genomics and Proteomics |
| Grande Auditório |
Chairs: Prof. Sir Robin Murray and
Lynn DeLisi, M.D.
Aida Ruiz -Molecular Genetic
Analyses of Schizophrenia in South America
Sinitia Belangero - Functional Polymorphisms of
DGCR2 Gene may Play a Role on Schizophrenia pathogenesis and
on antipsychotics treatment response
JennyGarcia-Valencia - Association between
NOS1AP Gene and Clinical Subtypes of Schizophrenia
Martinus van de Bilt - Greater Prevalence of
Ultra-rapid Drug Metabolizers between Refractory
Schizophrenia Patients? A Pharmacogenetic Study
Daniel Martins-de-Souza - What does Proteomics
in Human Brain Tissue tell us about Schizophrenia?
Marcos Santoro - Expression of
Neurotransmitter Receptor and Regulator Genes in the
Prefrontal Cortex in a New Animal Model of Schizophrenia:
the Spontaneous Hypertensive Rats (SHR) |
| 2:30 pm - 4:00 pm |
Oral Session II - Boundaries of
Psychotic Disorders |
| Auditório Amarelo |
Chairs: Wagner Gattaz, M.D.,
Ph.D. & Jorge Ospina-Duque, M.D. Natalia Mota -
Graph Analysis of Psychotic Speech: Differential Diagnosis
Between Schizophrenia and Mania
Rafael de Souza - The Efficacy of Lithium in
Psychotic Features of Bipolar Mania: Early Improvement and
its Association with Later Response
Sheila Caetano - Dysfunctional Family
Environment in Offspring of Parents with Psychotic and
Non-Psychotic Bipolar Disorder
Maristela Spanghero - Psychotic and
Non-psychotic Unipolar Depression: Clinical and Biological
Differences
Ruda Alessi - Risk Factors for the Occurrence
of Schizophrenia-like Psychosis in Patients with Temporal
Lobe Epilepsy.
Antonio Sa - Obsessive-compulsive Symptoms and
Eisorder in Patients with Schizophrenia Treated with
Clozapine or Haloperidol |
| 2:30 pm - 4:00pm |
Oral Session III - Neurochemistry/Psychopharmacology |
| Auditório Verde |
Chairs: John Kane, M.D. and Deepak D'Souza, M.D.
Deepak D'Souza -"Gone to Pot": Evidence from
Laboratory Studies with Δ-9-THC
Linda Scoriels - Differential Metabolic Profile in
First Episode Psychosis Supports the Glutamate Theory for
Schizophrenia
Ary Gadelha - Plasma Oligopeptidase Activity is
lower in Schizophrenic Patients Compared to Healthy Controls
Mariana Calzavara - D1 and D2 Dopamine Receptors
Modulate The Contextual Fear Conditioning Deficit Presented
By SHR: Strenghthening This Animal Model Of Emotional
Processing Deficits In Schizophrenia
Felipe Pacheco - Prenatal Exposure to Cigarette
Smoke Causes Persistent Changes in the Oxidative Balance and
in DNA Structural Integrity in Rats Submitted to the Animal
Model of Schizophrenia
Victor Ricardo - Neonatal Hypoxia Enhances
Dopamine-mediated Effects of Cocaine Repeated Administration
in Adult Mice |
| 4:00 pm - 4:30 pm |
Coffee Break |
| 4:30 pm - 6:00 pm |
Oral sessions IV |
| * Concurrent oral sessions – in 2 rooms simultaneously (topics covered: epidemiology, genomics, neuroimaging, animal models, treatment and side effects). Each including six presentations (15 minutes) of recent research studies by South American groups, with time for discussion (30 minutes) with international experts from SIRS. |
| 4:30 pm - 6:15 pm |
Oral Session IV - Neuroimaging |
| Grande Auditório |
Chairs: Rene Kahn, M.D., Ph.D. and Geraldo Busatto, M.D.
Pedro Rosa - Brain Structure and the Prediction of
Outcome in First-episode Schizophrenia-spectrum Disorders
and Affective Psychosis: a population-based study
Mauricio Serpa - Corpus Callosum Volumes in
Recent-onset Schizophrenia Predict Outcome of Positive
Symptom Severity
Pedro Rosa - Structural Brain Changes in First
Episode Schizophrenia: a 4-5 Year Follow-up Study Using MRI
Clarissa Trzesniak - Longitudinal Follow-up of
Cavum Septum Pellucidum and Adhesio Interthalamica
alterations in First-Episode Psychosis: a population-based
MRI study
Marcus Zanetti - Neuroanatomical Pattern
Classification of MRI Data: Discrimination of Different
Psychotic Disorders at the First Episode
Silvia Arcuri - Functional Disconnectivity and
Formal Thought Disorder in schizophrenia: Integrating
clinical, neuropsychological, neuroimaging and functional
connectivity data
Silvia Arcuri -Faulty Suppression of Irrelevant
Material in Thought Disordered Schizophrenic Patients
Associated with Attenuated Frontal and Temporal Brain
Activation |
| 4:30 pm - 6:00 pm |
Oral Session V - Treatment/Health Care |
| Auditório Amarelo |
Chairs: Helio Elkis, M.D., Ph.D. and Eduardo Leiderman,
M.D. Elaine Elisabetsky - Traditional Medical
Systems as Sources of New Psychoactive Drugs: the Case of
the Putative Antipsychotic Alstonine
Ana Silveria - Low Recognition of Refractory
Schizophrenia in The Public Mental Health System in São
Paulo – Brazil
Eliza Barreto - A Preliminary Controlled trial of
Cognitive Behavioral Therapy in Clozapine Resistant
Schizophrenia
Eduardo Leiderman - Stigmatizing Bbeliefs and
Attitudes of Mental Health Professionals Towards People with
Schizophrenia
Gisele Huf - TREC-SAVE*: A Randomised Trial
Comparing Mechanical Restraints with Use of Seclusion for
Aggressive Patients in Psychiatric Hospitals. Trial
registration: ISRCTN 4945427
Andre Brunoni - Cardiovascular risk factors in
patients with first-episode psychosis: a population-based
study in São Paulo, Brazil. |
| 4:30 pm - 6:00 pm |
Oral Session VI- Cognition/Psychopathology |
| Auditório Verde |
Chairs: Salvador Guinjoan, M.D., Ph.D. and eduardo
Mizraji, M.D. Salvador Guinjoan - Emotion
Processing and Social Cognition in Patients with
Schizophrenia and Unaffected First Degree Relatives
Elisa Dias - Visual Search Impairments in
Schizophrenia
Vanessa Ota - UFD1L Variants and Cognitive
Performance
Eduardo Martinho - BDNF Val66Met Polymorphism,
Cognition and Clinical Symptomatology in a Brazilian
Population-based Sample of Individuals with First Episode
Psychosis.
Rogerio Panizzutti - Increased Serum Levels of
D-serine Correlate with Cognitive Gains Induced by
Neuroplasticity-based Cognitive Training in Schizophrenia.
Eduardo Mizraji - Neurocomputational Models as an
Exploratory Environment for Schizophrenia Research |
